November 22, 2011
SEC Comment Watch: staff presses Amgen for litigation disclosures
By Thomson Reuters Accelus – Staff
The SEC appears to be dissatisfied with the “vagaries of litigation” fallback when it comes to risk disclosure, as correspondence with Amgen, Inc. will attest…
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.